Senolytic Therapeutics Companies
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Founded Date:
2017-01-01
Investor Type:
For Profit
Estimated Revenue:
$1M to $10M
Total Funding:
583303
Investors Number:
7
Employee Number:
1-10
Number Of Exists:
1-10
Last Funding Type:
Grant
Industry:
BioTech & Health Care
Technology:
AgeTech
Headquarters:
Barcelona, Catalonia, Spain
Funding Status:
Seed
Last Funding Date:
2018